REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/10/2026
Back to search
Official data from USPTO
QUILLICHEW ER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QUILLICHEW ER
ST13
US500000086817633Class
5
Filing
86817633
Registration
5120845
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
01/11/2026
Trademark type
Word
Nice classes
5
Filing date
11/12/2015
Registration date
01/10/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/03/2023
Last transaction
01/11/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/18/2016
First use in commerce
04/18/2016
Drawing code
4
Owner type
03
Owner location
Monmouth Junction, NJ
Examiner
MARTIN,CHRISTINE C
Law office
L40
Current location
TMEG LAW OFFICE 104
Holders and representatives
Holders
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc.
Representatives
Cathy A. Kodroff Howson & Howson LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder
Publications
History of USPTO decisions and trademark events.
28 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/03/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/03/2023
E815
TEAS SECTION 8 & 15 RECEIVED
06/17/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/05/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/05/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/07/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/06/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/02/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/28/2016
IUAF
USE AMENDMENT FILED
11/09/2016
EISU
TEAS STATEMENT OF USE RECEIVED
11/09/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/29/2016
EX1G
SOU EXTENSION 1 GRANTED
10/27/2016
EXT1
SOU EXTENSION 1 FILED
10/27/2016
EEXT
SOU TEAS EXTENSION RECEIVED
10/27/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/17/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/22/2016
PUBO
PUBLISHED FOR OPPOSITION
03/22/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2016
DOCK
ASSIGNED TO EXAMINER
02/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2015
NWAP
NEW APPLICATION ENTERED
11/16/2015
Continuous trademark protection
Get notified about every new filing that threatens QUILLICHEW ER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.